Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia-Reference-Cited by-同舟云学术

Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia

Published:2022-03 Issue: Volume:27 Page:23-26
ISSN:2210-7789
Container-title:Pregnancy Hypertension
language:en
Short-container-title:Pregnancy Hypertension

Author:

Wong Georgia P.,Andres Faith,Walker Susan P.,MacDonald Teresa M.,Cannon Ping,Nguyen Tuong-Vi,Keenan Emerson,Hannan Natalie J.,Tong Stephen,Kaitu'u-Lino Tu'uhevaha J.

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Internal Medicine

Reference25 articles.

1. Short-term costs of preeclampsia to the United States health care system;Stevens;Am. J. Obstet. Gynecol.,2017

2. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial;Chappell;Lancet,2019

3. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction;Ong;J. Matern. Fetal Neonatal Med.,2004

4. Activin signalling and pre-eclampsia: from genetic risk to pre-symptomatic biomarker;Williamson;Cytokine,2015

5. Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility;Stoikos;Hum. Reprod.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential biomarkers for late-onset and term preeclampsia: A scoping review;Frontiers in Physiology;2023-03-10

2. Hypertension in Pregnancy: What We Now Know;Current Opinion in Nephrology & Hypertension;2022-11-16

3. Disturbed trophoblast transition links preeclampsia progression from placenta to the maternal syndrome;2022-10-11